ReviewClinical & developmental immunology2012
Newly described clinical and immunopathological feature of dermatitis herpetiformis.
Review in Clinical & developmental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 32 citations in OpenAlex.
- Article
- Skin gluten-related disorders: new and old cutaneous manifestations to be considered.Frontiers in medicine · 2023Review
- Dermatitis Herpetiformis: An Update on Diagnosis, Disease Monitoring, and Management.Medicina (Kaunas, Lithuania) · 2021Review
- Evaluation of a Bi-Analyte Immunoblot as a Useful Tool for Diagnosing Dermatitis Herpetiformis.Diagnostics (Basel, Switzerland) · 2021Article
- Reply letter to "An update on direct immunofluorescence for diagnosing dermatitis herpetiformis". Could granular C3 deposits at the dermal epidermal junction be considered a marker of "cutaneous gluten sensitivity"?Postepy dermatologii i alergologii · 2021Article
- Comment on "Dermatitis herpetiformis in an African woman", the importance of direct immunofluorescence assay.The Pan African medical journal · 2020Article
- Diagnosis of Autoimmune Blistering Diseases.Frontiers in medicine · 2018Review
- Dermatitis herpetiformis in an African woman.The Pan African medical journal · 2018Article
- Identifying novel biomarkers through data mining-a realistic scenario?Proteomics. Clinical applications · 2015Review
- The diagnosis and treatment of dermatitis herpetiformis.Clinical, cosmetic and investigational dermatology · 2015Review
- Fibrillar IgA staining - An uncommon finding in dermatitis herpetiformis.Indian journal of dermatology, venereology and leprologyArticle
- Educational Case: Dermatitis Herpetiformis.Academic pathologyArticle
- Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatitis herpetiformis (DH) is an inflammatory cutaneous disease with typical histopathological and immunopathological findings clinically characterized by intensely pruritic polymorphic lesions with a chronic-relapsing course. In addition to classic clinical manifestations of DH, atypical variants are more and more frequently reported and histological and immunological are added to them, whereas the impact on quality of life of patients with DH is increasingly important to a certain diagnosis. The aim of this paper is to describe all the possible clinical, histological, and immunological variants of DH in order to facilitate the diagnosis of a rare disease and, therefore, little known.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.